Phase
Condition
Hearing Loss
Deafness
Hearing Impairment
Treatment
Mi2000 TICI
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Minimum age of eighteen (18) years at time of enrolment
Bilateral sensorineural hearing loss with no or limited benefit from a hearing aid (>70 dB HL PTA4)
Post-lingual onset of deafness
No or limited benefit from hearing aids for less than 10 years and an expectedbenefit from cochlear implantation
A maximum score of 50% on a word test in the language of the test centre in the earto be implanted in the best aided condition
Fluency in the test language with excellent proficiency, as appropriate to performspeech testing
Functional auditory nerve
General health condition, psychological and emotional condition deemed compatiblewith the treatment and tests performed in this study
Pre-operative assessment according to the local professional standards
Candidate is highly motivated and has realistic expectations about the expectedbenefit of the implant and shall understand the importance of returning to theimplant centre for regular speech processor programming, assessment sessions andtraining
Realistic expectations, as deemed appropriate by the implanting surgeon/implantboard
Evidence of up-to-date vaccinations against meningitis, as per recommendations bythe applicable national body
Signed and dated informed consent before the start of any study-specific procedure
Exclusion
Exclusion Criteria:
Lack of compliance with any inclusion criterion
Previously having received an implant on the location chosen for placing thecochlear implant
Having received a hearing implant from another manufacturer than MED-EL on thecontralateral ear
Pre-existing condition known to necessitate MRI scans after implantation of theMi2000 TICI
Women being pregnant or nursing
Women of childbearing age not reporting to use effective contraception
The individual is known to be intolerant of the materials used in the implant orother required accessories including medical grade silicone, parylene C, titanium,platinum iridium, platinum, stainless chromate steel, thermoplastic elastomere (TPE-S), thermoplastic elastomere (SEBS), mixture of polycarbonate andacrylonitrile-butadiene-styrol polymer (PC/ABS), polyamide, liquid crystal polymer,silicone and polyurethane-coated silicone rubber)
Absence of cochlear development
The cause of deafness is non-functionality of the auditory nerve and/or the upperauditory pathway
Medical contra-indications to middle ear and/or inner ear surgery, and/oranaesthesia
External or middle ear infections are present
The tympanic membrane is perforated in the ear to be implanted
Anatomic abnormalities are present that would prevent appropriate placement of thestimulator housing in the bone of the skull, or prevent placement of the chosenelectrode array into the cochlea (including ossification of the cochlea)
The psychological status of the individual is unstable
The individual has unrealistic expectations
Acute cholesteatoma
History of vestibular schwannoma
Unstable Meniere's disease
Auditory Neuropathy
Epilepsy not responding to treatment
Permanent inability and/or unwillingness to participation in post-operative care andrehabilitation
Known intellectual disability and/or psychological diseases
Participation in other pharmacological clinical trials within four weeks prior toenrolment
Anything that, in the opinion of the Investigator, would place the subject atincreased risk; preclude the subject's full compliance with or completion of thestudy
Study Design
Study Description
Connect with a study center
AKH Wien
Wien, 1090
AustriaSite Not Available
UZA Antwerpen
Antwerp, 2650
BelgiumSite Not Available
CHU Liège
Liège, 4000
BelgiumSite Not Available
LMU Munich
München, Bavaria 81377
GermanySite Not Available
UKW Würzburg
Würzburg, Bavaria 97080
GermanySite Not Available
The Institute of Physiology and Pathology of Hearing
Nadarzyn, 05-830
PolandSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.